The global pharmaceutical industry is said to be a huge and growing market in the world.
We are a stem cell bio-venture company conducting research and development that has never been done before.
The article introducing our company is in “ASTEM NEWS No.82” published by the Advanced Scientific Technology & Management Research Institute of Kyoto (ASTEM). “ASTEM NEWS No.82″ PDF (Our article is on page 16)
Media
In March, we were notified by Senshu Ikeda Bank, Ltd. that we had received the “16th Innovation Research and Development Grant” Award for Excellence. Due to the spread of the new Corona virus, the award ceremony was not held, but today we received a certificate of commendation and a commemorative gift from Senshu Ikeda Bank, Ltd.
Awards
On February 28, 2020, our representative spoke at the “Kyoto University Life Science Showcase @UCSD” held in San Diego, U.S., and made a presentation on the “development of regenerative medicine products using ‘Oligogenie'”.
Events
Our company was introduced on the Kyoto Prefecture website. ■Oligogen Inc. (Kyoto Company Introduction) （The linked source） http://www.pref.kyoto.jp/sangyo-sien/index.html http://www.pref.kyoto.jp/sangyo-sien/qol.html
Media
On January 31, 2020, the Company conducted a capital increase (Series A-2) by issuing new shares through a third-party allotment to three venture capital firms.
Funding
Our project was selected as a grant project. Grants name：FY2019 Project to Promote “Corporate Forest/University-Industry Forest” (Business Promotion Course) Theme：Research and development of GMP production of OligoGenie cells for clinical use Issuing authority：KYOTO Industrial Support Organization 21
Grants
